PhD Anja Pišlar

PhD Anja Pišlar
no.: 32035 source: ARIS

researcher – active in research organisation
  anja.pislarat signffa.uni-lj.si
Edit
Research activity

Code Science Field Subfield
4.06.00  Biotechnical sciences  Biotechnology   
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
624.8
A''
57.68
A'
359.05
A1/2
456.85
CI10
1,901
CImax
250
h10
24
A1
2.25
A3
0.07
Data for the last 5 years (citations for the last 10 years) on May 14, 2026; Data for score A3 calculation refer to period 2020-2024 (2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 60  2,120  1,807  30.12 
Scopus 61  2,260  1,935  31.72 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Selena Horvat   Bologna doctoral studies    55893 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2009 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2013 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:21.3%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  10/11/2009  Assistant  Researcher  Associate professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J1-70053  Multitarget compounds with unexplored combination of activities for the treatment of Alzheimer's disease (MuTaCAD)   4/1/2026 - 3/31/2029  PhD Stanislav Gobec   3,925 
2. J3-70144  Development of new peptide therapies for the treatment of autoimmune and allergic diseases   3/1/2026 - 2/28/2029  PhD Peter Korošec   3,751 
3. J1-70052  Light-Driven Expansion of Chemical Space for Challenging Targets (LUX: BLI-AS-MS)   3/1/2026 - 2/28/2029  PhD Janez Ilaš   1,742 
4. J1-70042  Neuroprotective and regenerative activity of γ-enolase as new therapeutic strategy in neuroinflammation-induced neurodegeneration   3/1/2026 - 2/28/2029  PhD Anja Pišlar   3,035 
5. N1-0411  Two-photon-activated targeted cancer therapies   3/1/2025 - 2/29/2028  PhD Anja Pišlar   1,328 
6. J3-60067  Cathepsin Targeted Immunotherapy for Pancreatic Cancer Treatment -CATIMMPACT   1/1/2025 - 12/31/2027  PhD Milica Perišić Nanut   2,361 
7. N1-0277  Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease   1/1/2023 - 12/31/2025  PhD Stanislav Gobec   1,447 
8. J3-3071  Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy   10/1/2021 - 3/31/2025  PhD Ana Mitrović   2,929 
9. J1-2484  Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis   9/1/2020 - 8/31/2023  PhD Stanislav Gobec   4,308 
10. J4-1776  Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F   7/1/2019 - 6/30/2022  PhD Janko Kos   3,421 
11. J3-9267  Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease   7/1/2018 - 6/30/2021  PhD Anja Pišlar   3,096 
12. J4-9327  Targeting, imaging and treating of colorectal cancer with safe theranostic bacteria   7/1/2018 - 6/30/2021  PhD Aleš Berlec   2,714 
13. J4-8227  Preprečevanje rezistence tumorskih celic na antiproteazno terapijo z inhibitorji katepsina X. (Slovene)   5/1/2017 - 4/30/2020  PhD Janko Kos   5,281 
14. L1-8157  Razvoj multifunkcionalnih učinkovin za zdravljenje Alzheimerjeve bolezni (Slovene)   5/1/2017 - 4/30/2020  PhD Stanislav Gobec   5,142 
15. J4-6811  Vloga inhibitorjev cisteinskih proteaz v citotoksičnem delovanju naravnih celic ubijalk na tumorske celice (Slovene)   7/1/2014 - 6/30/2017  PhD Janko Kos   2,889 
16. J4-5529  Nitroksolin in njegovi derivati kot nova protitumorska zdravila (Slovene)   8/1/2013 - 7/31/2016  PhD Janko Kos   6,812 
17. J1-5450  Proteinsko načrtovanje rekombinantnih probiotičnih mlečnokislinskih bakterij za zdravljenje sindromov vnetega črevesa (Slovene)   8/1/2013 - 7/31/2016  PhD Borut Štrukelj   2,660 
18. J4-4123  Inhibitorji cisteinskih karboksipeptidaz kot regulatorji avtoimunskih in nevrodegenerativnih procesov (Slovene)   7/1/2011 - 6/30/2014  PhD Janko Kos   7,112 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P4-0127  Pharmaceutical biotechnology: Science for health   1/1/2019 - 12/31/2027 PhD Anja Pišlar   5,909 
2. P4-0127  Pharmaceutical biotechnology: Science for Health   1/1/2015 - 12/31/2018 PhD Janko Kos   5,560 
3. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2009 - 12/31/2014 PhD Janko Kos   6,094 
Confirmation required
Views history
Favourite